CX3CL1 and breast angiosarcoma: Poly (I:C)-treated primary cholangiocytes, mimicking biliary damage in BA, also trigger a stronger release of chemokine (C-X3-C motif) ligand 1 (CX3CL1) and the subsequent attraction of malfunctional natural killer (NK) cells (74).